Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.

Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

Dr Reddy's Laboratories had received the manufacturing licence for semaglutide in December 2024 and it began production in ...

Regeneron’s trial shows semaglutide combos improve fat loss while preserving muscle in obesity treatment. Read more here.

The next big test is whether using Pluvicto can delay the advancement of prostate cancer enough to delay chemical castration, ...

The FDA launched a generative artificial intelligence tool designed to help employees, such as scientific reviewers and ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...